Alert: New Earnings Report (5/20/24)-Taro Pharmaceutical Industries L (NYSE: TARO).
Taro Pharmaceutical Industries L (NYSE: TARO) has reported E.P.S. of $0.40 for its fourth fiscal quarter (ending March 31) versus $0.18 for the same period a year ago. For the latest four quarters through March […]